Role of presensitization and donor-recipient crossmatching in corneal graft outcome

Cornea

Volumn 17, Issue 2, 1998, Pages 141-145

  Des Marchais, Béatrice ^a   Bazin, Richard ^a   Boisjoly, Hélène M ^b   Laughrea, Patricia A ^a   Dubé, Ide ^a   Lille, Simonne ^a   Roy, Raynald ^a  

^a LAVAL UNIVERSITY   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

Corneal graft rejection; Crossmatch; HLA matching; Pretransplant antibody

Indexed keywords

ANTIBODY SPECIFICITY; ARTICLE; CORNEA TRANSPLANTATION; GRAFT REJECTION; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; ORGAN DONOR; PATIENT SELECTION; PRIORITY JOURNAL; SENSITIZATION; TREATMENT OUTCOME;

EID: 0031950870     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-199803000-00004     Document Type: Article

References (21)

1. Boisjoly HM, Tourigny R, Bernier J, Bazin R, Laughrea PA, Dubé I. Risk factors of corneal graft failure. Ophthalmology 1993;100: 1728-35.
2. CCTS Research Group (The Collaborative Corneal Transplantation Studies). Effectiveness of histocompatibility matching in high-risk corneal transplantation. Arch Ophthalmol 1992;110:1392-403.
3. Boisjoly HM, Roy R, Dubé I, et al. HLA-A, -B and -DR matching in corneal transplantation. Ophthalmology 1986;93:1290-7.
4. Stark WJ, Taylor HR, Bias W, Maumenee AE. Histocompatibility (HLA) antigens and keratoplasty. Am J Ophthalmol 1978;86:595-604.
5. Terasaki PI, Cicciarelli J. Sensitization and its role in transplantation. Organ Transplant Replacement 1988;10:196-208.
6. Roy R, Boisjoly HM, Wagner E, et al. Pre and post-transplant antibodies in human corneal transplantation. Transplantation 1992;54:463-7.
7. Patel R, Terasaki PI. Significance of the positive crossmatch in kidney transplantation. N Engl J Med 1969;280:735-9.
8. Iwaki Y, Terasaki PI. Sensitization effect. Los Angeles, UCLA Tissue Typing Laboratory. Clin Transpl 1986;1:257-65.
9. Loh E, Bergin J, Couper GS, Mudge GH. Role of panel-reactive antibody cross-reactivity in predicting survival after orthotopic heart transplantation. J Heart Lung Transpl 1994;3:194-201.
10. Holan V, Haskova Z, Filipec M. Transplantation immunity and tolerance in the eye. Transplantation 1996;162:1050-4.
11. Völker-Dieben HJM, Kok-Van Alphen CC, Lansbergen Q, Persijn GG. The effect of positive HLA-A and -B matching on corneal graft survival. Acta Ophthalmol 1982;60:203-12.
12. Roy R, Des Marchais B, Bazin R, Boisjoly HM, Dubé I, Laughrea PA. Role of ABO and Lewis blood group antigens in donor-recipient compatibility of corneal transplantation rejection. Ophthalmology 1997;104:508-12.
13. CCTS Research Group. The association of lymphocytotoxic antibodies with corneal allograft rejection in high risk patients. Transplantation 1995;59:21-7.
14. Roy R, Lachance JG, Fradet Y, Hébert J. Characterization of lymphocytotoxic antibodies in renal transplantation. Transplantation 1981;31:31-3.
15. Snedecor GW, Cochran WG. Statistical methods. Ames: Iowa State University Press, 1980:507.
16. Foulks GN, Sanfilippo F. Beneficial effects of histocompatibility in high-risk corneal transplantation. Am J Ophthalmol 1982;94: 622-9.
17. Nicholls SM, Bradley BB, Easty D. Effect of mismatches for major histocompatibility complex and minor antigens on corneal graft rejection. Invest Ophthalmol Vis Sci 1991;32:2729-34.
18. Jager MJ, Völker-Dieben HJ, Vos A, Broersma L, Kok FG, van der Gaag R. Cellular and humoral anticorneal immune response in corneal transplantation. Arch Ophthalmol 1991;109:972-7.
19. Howell DN, Burchette JL, Paolini JF, Geier SS, Fuller JA, Sanfilippo F. Characterization of a novel human corneal endothelial antigen. Invest Ophthalmol Vis Sci 1991;32:2473-82.
20. Baumgartner I, Asenbauer TT, Kaminski SL, Grabner G, Mayr WR. Retinal pigment epithelial cells in post mortem HLA typing of corneal donors. Invest Ophthalmol Vis Sci 1992;33:1940-5.
21. CCTS Research Group. Risk factors for corneal graft failure and rejection in the Collaborative Corneal Transplantation Studies. Ophthalmology 1994;101:1536-47.